cliexa introduced innovative smart intake solutions based on dynamic workflows within EMR systems. We transcribed real-time patient information into EMR-integrated insights by onboarding personalized patient information from multiple data sources with bi-directional EMR integration. During this foundational period, we partnered with and received investment from the American College of Cardiology, establishing our focus on cardiovascular care excellence.

cliexa launched in clinical settings with multi-ancillary services, enabling cliexaAI's first foundational structure leveraging true clinical reasoning through our patented clinical indexing engine. We extended the cliexa platform capabilities by integrating cardiovascular risk models and multicomorbidity management while enabling cliexa deployment in integrated pain management settings. Our continued partnership and investment from the American College of Cardiology allowed us to focus on cardiovascular risk assessment and multicomorbidity care coordination.

By retraining cliexaAI on over 12 million real patient data points, cliexa enabled a proprietary closed-loop LLM infrastructure that seamlessly connects patient, provider, and biller journeys. We validated our solution through the Mayo Clinic Platform and secured partnership and investment from Mayo Clinic Fund, demonstrating the clinical efficacy and scalability of our AI-driven healthcare solutions. This period marked our transformation into a comprehensive healthcare AI platform capable of managing complex patient care workflows at enterprise scale.